Inhibition of PI3K by PX-866 Prevents Transforming Growth Factor-α–Induced Pulmonary Fibrosis
Timothy D. Le Cras(Cincinnati Children's Hospital Medical Center), William D. Hardie(Cincinnati Children's Hospital Medical Center)
Cited by 62
Related Papers
Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study
|The Journal of Pediatrics|2017|201
Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation
|Angiogenesis|2020|55
p70 ribosomal S6 kinase regulates subpleural fibrosis following transforming growth factor-α expression in the lung
|American Journal of Physiology-Lung Cellular and Molecular Physiology|2015|22
How we use angiopoietin‐2 in the diagnosis and management of vascular anomalies
|Pediatric Blood & Cancer|2024|14
NRAS <sup>Q61R</sup> mutation drives elevated angiopoietin‐2 expression in human endothelial cells and a genetic mouse model
|Pediatric Blood & Cancer|2024|13